NYSE:AVNS

Avanos Medical (AVNS) Stock Forecast, Price & News

$20.23

+0.13 (+0.65%)

(As of 09/22/2023 ET)

Compare

Today's Range: $20.11
▼
$20.37
50-Day Range: $19.93
▼
$26.31
52-Week Range: $19.32
▼
$31.99

Volume: 332,686 shs
Average Volume: 399,366 shs
Market Capitalization: $948.18 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $31.00

Avanos Medical MarketRank™ Forecast

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 53.2% Upside
$31.00 Price Target
Short Interest: Healthy
1.89% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.84
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 44.86%
From $1.07 to $1.55 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.31 out of 5 stars

Medical Sector

282nd out of 967 stocks

Surgical Appliances & Supplies Industry

9th out of 19 stocks

3.0

Analyst's Opinion

Consensus Rating
Avanos Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 1 hold rating, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $31.00, Avanos Medical has a forecasted upside of 53.2% from its current price of $20.23.
Amount of Analyst Coverage
Avanos Medical has only been the subject of 1 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
1.89% of the float of Avanos Medical has been sold short.
Short Interest Ratio / Days to Cover
Avanos Medical has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Avanos Medical has recently increased by 7.99%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Avanos Medical does not currently pay a dividend.
Dividend Growth
Avanos Medical does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for AVNS.

2.1

News and Social Media Coverage

News Sentiment
Avanos Medical has a news sentiment score of 0.84. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Avanos Medical this week, compared to 3 articles on an average week.
MarketBeat Follows
Only 1 people have added Avanos Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Avanos Medical insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 2.90% of the stock of Avanos Medical is held by insiders.
Percentage Held by Institutions
93.84% of the stock of Avanos Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Avanos Medical are expected to grow by 44.86% in the coming year, from $1.07 to $1.55 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Avanos Medical is -25.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Avanos Medical is -25.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Growth Ratio
Avanos Medical has a PEG Ratio of 1.51. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Avanos Medical has a P/B Ratio of 0.73. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Avanos Medical (NYSE:AVNS) Stock

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy and OrthogenRx's knee osteoarthritis pain relief injection products. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

AVNS Price History

30 days | 90 days | 365 days | Advanced Chart

AVNS Stock News Headlines

September 17, 2023 | americanbankingnews.com

Critical Contrast: Avanos Medical (NYSE:AVNS) & OceanTech Acquisitions I (NASDAQ:OTEC)

September 12, 2023 | finance.yahoo.com

Avanos Medical, Inc. to Present at the CL King Annual Best Ideas Conference

September 24, 2023 | Behind the Markets (Ad)

6.5 Million Americans Are DESPERATE for This New Drug from One Tiny Company

Decades of pent-up demand for this "first-ever" treatment could give you WINDFALL PROFITS... Click here to learn more >>>

August 11, 2023 | finance.yahoo.com

Bearish: Analysts Just Cut Their Avanos Medical, Inc. (NYSE:AVNS) Revenue and EPS estimates

August 11, 2023 | finance.yahoo.com

Avanos Medical, Inc. (NYSE:AVNS) Q2 2023 Earnings Call Transcript

August 10, 2023 | markets.businessinsider.com

JMP Securities Remains a Hold on Avanos Medical (AVNS)

August 10, 2023 | finance.yahoo.com

Q2 2023 Avanos Medical Inc Earnings Call

August 9, 2023 | finance.yahoo.com

Avanos Medical, Inc. Announces Second Quarter 2023 Results

September 24, 2023 | Behind the Markets (Ad)

BREAKING: Tiny biotech successfully treats blindness

There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.

August 8, 2023 | finance.yahoo.com

Avanos Medical, Inc. to Present at the UBS MedTech, Tools and Genomics Summit 2023

August 3, 2023 | finance.yahoo.com

Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2023 Financial Results

August 1, 2023 | finance.yahoo.com

Avanos Medical (NYSE:AVNS) Is Experiencing Growth In Returns On Capital

July 24, 2023 | finance.yahoo.com

AVNS vs. EW: Which Stock Is the Better Value Option?

July 16, 2023 | msn.com

Avanos Medical: Leaning Up, Attractive Returns On Incremental Capital, Reiterate Buy

July 3, 2023 | finance.yahoo.com

What Is Avanos Medical, Inc.'s (NYSE:AVNS) Share Price Doing?

June 28, 2023 | finance.yahoo.com

Avanos Medical Supports New Interventional Procedure Recommendations from the UK's National Institute of Health and Care Excellence (NICE)

June 26, 2023 | bizjournals.com

Avanos Medical sells respiratory business for $110M, buys Canadian company

June 21, 2023 | markets.businessinsider.com

Avanos Medical (AVNS) Gets a Hold from JMP Securities

June 20, 2023 | msn.com

Avanos agrees to acquire Toronto-based Diros Technology

June 19, 2023 | finance.yahoo.com

Avanos Medical, Inc. Announces Agreement to Acquire Diros Technology Inc.

June 13, 2023 | finance.yahoo.com

Avanos Medical, Inc. To Host Investor Day on June 20, 2023

June 8, 2023 | markets.businessinsider.com

JMP Securities Keeps Their Hold Rating on Avanos Medical (AVNS)

June 8, 2023 | finance.yahoo.com

Masimo (MASI) Down 6% Since Last Earnings Report: Can It Rebound?

June 8, 2023 | msn.com

Avanos Medical climbs 7% with the sale of Respiratory Health business to SunMed

June 8, 2023 | markets.businessinsider.com

Avanos Medical Divests Respiratory Health Business To SunMed

June 8, 2023 | finance.yahoo.com

Avanos Medical, Inc. Announces Sale of Respiratory Health Business to SunMed Group Holdings, LLC

June 7, 2023 | finance.yahoo.com

Avanos Medical, Inc.'s (NYSE:AVNS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

See More Headlines

Receive AVNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter.

AVNS Company Calendar

Last Earnings: 8/09/2023
Today: 9/23/2023
Next Earnings (Estimated): 11/01/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Surgical appliances & supplies
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSE:AVNS
CUSIP: N/A
CIK: 1606498
Web: avanos.com
Phone: (844) 428-2667
Fax: N/A
Employees: 4,044
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $31.00
High Stock Price Forecast: $34.00
Low Stock Price Forecast: $28.00
Forecasted Upside/Downside: +53.2%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.78)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 18.91
P/E Growth: 1.51
Net Income: $50.50 million
Net Margins: -4.61%
Pretax Margin: 5.74%
Return on Equity: 5.49%
Return on Assets: 4.01%

Debt

Debt-to-Equity Ratio: 0.16
Current Ratio: 3.16
Quick Ratio: 2.23

Sales & Book Value

Annual Sales: $820 million
Price / Sales: 1.16
Cash Flow: $2.73 per share
Price / Cash Flow: 7.42
Book Value: $27.77 per share
Price / Book: 0.73

Miscellaneous

Outstanding Shares: 46,870,000
Free Float: 45,514,000
Market Cap: $948.18 million
Optionable: Optionable
Beta: 0.90

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. Joseph F. Woody (Age 57)
CEO & Director
Comp: $2.37M

Mr. Michael C. Greiner (Age 50)
Sr. VP, CFO & Chief Transformation Officer
Comp: $940.45k

Ms. Mojirade James (Age 56)
Sr. VP, Gen. Counsel & Corp. Sec.
Comp: $759.53k

Mr. Kerr W. Holbrook (Age 56)
Sr. VP, GM of Chronic Care & Chief Commercial Officer
Comp: $716.87k

Mr. John Joseph Hurley
Principal Accounting Officer & Controller

Mr. David Crawford
VP of FP&A and Investor Relations and Treasurer

Ms. Michelle Scharfenberg
Sr. VP and Chief Ethics & Compliance Officer

Mr. Scott Galovan
VP of Strategy & Corp. Devel.

John W. Cato
VP of HR

Mr. Lee Burnes
Sr. VP of Global R&D, Clinical and Medical Affairs

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

AVNS Stock - Frequently Asked Questions

Should I buy or sell Avanos Medical stock right now?: 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last twelve months. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" AVNS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AVNS, but not buy additional shares or sell existing shares.
View AVNS analyst ratings or view top-rated stocks.
What is Avanos Medical's stock price forecast for 2023?: 3 Wall Street research analysts have issued 12 month price objectives for Avanos Medical's stock. Their AVNS share price forecasts range from $28.00 to $34.00. On average, they expect the company's stock price to reach $31.00 in the next twelve months. This suggests a possible upside of 53.2% from the stock's current price.
View analysts price targets for AVNS or view top-rated stocks among Wall Street analysts.
How have AVNS shares performed in 2023?: Avanos Medical's stock was trading at $27.06 at the beginning of the year. Since then, AVNS shares have decreased by 25.2% and is now trading at $20.23.
View the best growth stocks for 2023 here.
Are investors shorting Avanos Medical?: Avanos Medical saw a increase in short interest during the month of August. As of August 15th, there was short interest totaling 805,800 shares, an increase of 6.8% from the July 31st total of 754,800 shares. Based on an average daily volume of 255,400 shares, the days-to-cover ratio is presently 3.2 days. Approximately 1.8% of the company's shares are short sold.
View Avanos Medical's Short Interest.
When is Avanos Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 1st 2023.
View our AVNS earnings forecast.
How were Avanos Medical's earnings last quarter?: Avanos Medical, Inc. (NYSE:AVNS) released its earnings results on Wednesday, August, 9th. The company reported $0.24 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.34 by $0.10. The business earned $169.40 million during the quarter, compared to analyst estimates of $186.30 million. Avanos Medical had a positive trailing twelve-month return on equity of 5.49% and a negative net margin of 4.61%. The firm's quarterly revenue was down 16.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.41 EPS.
What ETF holds Avanos Medical's stock ?: Invesco S&P SmallCap Health Care ETF holds 119,434 shares of AVNS stock, representing 1.06% of its portfolio.
What guidance has Avanos Medical issued on next quarter's earnings?: Avanos Medical updated its FY23 earnings guidance on Wednesday, August, 9th. The company provided EPS guidance of $1.05-$1.15 for the period, compared to the consensus earnings per share estimate of $1.52.

What is Joseph F. Woody's approval rating as Avanos Medical's CEO?: 32 employees have rated Avanos Medical Chief Executive Officer Joseph F. Woody on Glassdoor.com. Joseph F. Woody has an approval rating of 51% among the company's employees. This puts Joseph F. Woody in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Avanos Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly-Clark (KMB), CVS Health (CVS), Pfizer (PFE), Procter & Gamble (PG), Johnson & Johnson (JNJ), RTX (RTX), AT&T (T), Abbott Laboratories (ABT) and Alibaba Group (BABA).
What is Avanos Medical's stock symbol?: Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS."
Who are Avanos Medical's major shareholders?: Avanos Medical's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (15.64%), Dimensional Fund Advisors LP (6.68%), RGM Capital LLC (5.92%), Paradice Investment Management LLC (4.81%), State Street Corp (4.37%) and Westwood Holdings Group Inc. (3.67%).
View institutional ownership trends.
How do I buy shares of Avanos Medical?: Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Avanos Medical's stock price today?: One share of AVNS stock can currently be purchased for approximately $20.23.
How much money does Avanos Medical make?: Avanos Medical (NYSE:AVNS) has a market capitalization of $948.18 million and generates $820 million in revenue each year. The company earns $50.50 million in net income (profit) each year or ($0.78) on an earnings per share basis.
How many employees does Avanos Medical have?: The company employs 4,044 workers across the globe.
How can I contact Avanos Medical?: Avanos Medical's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The official website for the company is avanos.com. The company can be reached via phone at (844) 428-2667 or via email at investor.relations@avanos.com.

This page (NYSE:AVNS) was last updated on 9/24/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial